Literature DB >> 23340955

Unravelling molecular mechanisms in the fluorescence spectra of doxorubicin in aqueous solution by femtosecond fluorescence spectroscopy.

Pascale Changenet-Barret1, Thomas Gustavsson, Dimitra Markovitsi, Ilse Manet, Sandra Monti.   

Abstract

Doxorubicin (DOX) is a potent anti-tumoral agent widely used for cancer therapy. Despite numerous studies, the fluorescence properties of DOX, usually exploited for the characterization of the interaction with biological media, have until now led to controversial interpretations, mainly due to self-association of the drug in aqueous solution. We present here the first femtosecond study of DOX based on measurements with the fluorescence up-conversion technique in combination with time-correlated single photon counting using the same laser source. We provide evidence that fluorescence signals of DOX stem from monomers and dimers. DOX dimerization induces a dramatic decrease in the fluorescence quantum yield from 3.9 × 10(-2) to 10(-5) associated with the red shift of the fluorescence spectrum by ~25 nm. While the fluorescence lifetime of the monomer is 1 ns, the dimer fluorescence is found to decay with a lifetime of about 2 ps. In contrast to monomers, the fluorescence anisotropy of dimers is found to be negative. These experimental observations are consistent with an ultrafast internal conversion (<200 fs) between two exciton states, possibly followed by a charge separation process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340955     DOI: 10.1039/c2cp44056c

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  9 in total

1.  Multiphoton fluorescence lifetime imaging of chemotherapy distribution in solid tumors.

Authors:  Marjorie Carlson; Adrienne L Watson; Leah Anderson; David A Largaespada; Paolo P Provenzano
Journal:  J Biomed Opt       Date:  2017-11       Impact factor: 3.170

2.  Fluorescence properties of several chemotherapy drugs: doxorubicin, paclitaxel and bleomycin.

Authors:  Najme Sadat Hosseini Motlagh; Parviz Parvin; Fatemah Ghasemi; Fatemeh Atyabi
Journal:  Biomed Opt Express       Date:  2016-05-25       Impact factor: 3.732

3.  Fluorescence properties of doxorubicin in PBS buffer and PVA films.

Authors:  Sunil Shah; Anjali Chandra; Amanjot Kaur; Nirupama Sabnis; Andras Lacko; Zygmunt Gryczynski; Rafal Fudala; Ignacy Gryczynski
Journal:  J Photochem Photobiol B       Date:  2017-03-30       Impact factor: 6.252

4.  Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization.

Authors:  Thiruganesh Ramasamy; Tuan Hiep Tran; Hyuk Jun Cho; Jeong Hwan Kim; Yong Il Kim; Jae Yoon Jeon; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

5.  Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes.

Authors:  Dora Mehn; Patrizia Iavicoli; Noelia Cabaleiro; Sven Even Borgos; Fanny Caputo; Otmar Geiss; Luigi Calzolai; François Rossi; Douglas Gilliland
Journal:  Int J Pharm       Date:  2017-03-22       Impact factor: 5.875

6.  Magnetic field potential effects on the doxorubicin therapeutic activity in Ehrlich tumor growth.

Authors:  Magdy M Ghannam; Hanin A Al-Otaibi; Eman S Alanazy; Doaa Elnagar; Alaa R Fouad; Mohammes S AlAyed; Amany A Aly
Journal:  Saudi J Biol Sci       Date:  2021-02-11       Impact factor: 4.219

7.  Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells.

Authors:  Ilaria Genovese; Annarita Fiorillo; Andrea Ilari; Silvia Masciarelli; Francesco Fazi; Gianni Colotti
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

8.  Recellularized Colorectal Cancer Patient-derived Scaffolds as in vitro Pre-clinical 3D Model for Drug Screening.

Authors:  Francesca Sensi; Edoardo D'Angelo; Martina Piccoli; Piero Pavan; Francesca Mastrotto; Paolo Caliceti; Andrea Biccari; Diana Corallo; Luca Urbani; Matteo Fassan; Gaya Spolverato; Pietro Riello; Salvatore Pucciarelli; Marco Agostini
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

9.  Synergy of Chemo- and Photodynamic Therapies with C60 Fullerene-Doxorubicin Nanocomplex.

Authors:  Anna Grebinyk; Svitlana Prylutska; Oksana Chepurna; Sergii Grebinyk; Yuriy Prylutskyy; Uwe Ritter; Tymish Y Ohulchanskyy; Olga Matyshevska; Thomas Dandekar; Marcus Frohme
Journal:  Nanomaterials (Basel)       Date:  2019-10-30       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.